Type : Contract
ORDER FOR ILLUMINA NGS REAGENTS TO PERFORM DIAGNOSTIC CONFIRMATORY SEQUENCING IN SLSS Solicitation ID/Procurement Identifier: 1232SA20D0001 Ultimate Completion Date: Thu May 11 17:00:00 GMT 2023
ORDER FOR ILLUMINA NGS REAGENTS TO PERFORM DIAGNOSTIC CONFIRMATORY SEQUENCING IN SLSS Solicitation ID/Procurement Identifier: 1232SA20D0001 Ultimate Completion Date: Thu May 11 17:00:00 GMT 2023
The reagents provided by CareDx will fulfill this requirement. Without a secondary option for NGS reagents, there could be a very large delay in obtaining results for the clinicians. Additionally, even after the delay, there is a risk that the results may not be as specific as what would have been obtained by NGS. NGS offers the highest resolution results for HLA typing of transplant recipients and donors.
REAGENTS FOR THERMOFISHER NGS AND GENEXUS PLATFORMS Solicitation ID/Procurement Identifier: 36C24221D0044 Ultimate Completion Date: Wed Jan 31 18:00:00 GMT 2024
Without these reagents, the DNA cannot be properly prepared for Next Generation Sequencing, which will in turn restrict the FBI Laboratory's ability to validate NGS for casework implementation. The NEB reagents are the only reagents on the market that work with low quantities of DNA, allow for sample preparation in a single tube, and include looped DNA adapters.
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Fluidigm Corporation, South San Francisco, CA, for their Juno System equipment and reagents used for NGS library preparation for ongoing work in collaboration with the Broad Institute.
The contractor shall provide the necessary equipment and reagents to establish an independent field laboratory and NGS field sites, with the ability to sequence roughly 500 draft genomes per year.
A solicitation document will not be issued, and quotations will not be requested.The National Institutes of Health (NIH) intends to award a fixed price contract with a nine-month base period from 11/1/2023-8/31/2023 to CareDx Lab Solutions, Inc., West Chester, Pennsylvania 19382 on a sole source basis to provide the Next Generation Sequencing (NGS) reagents to the Department of Transfusion Medicine/Human Leukocyte Antigen (HLA) Lab at the NIH Clinical